Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines-Reference-Cited by-同舟云学术

Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines

Published:2018-04 Issue:4 Volume:29 Page:323-333
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Koukourakis Michael I.,Kakouratos Christos,Kalamida Dimitra,Mitrakas Achilleas,Pouliliou Stamatia,Xanthopoulou Erasmia,Papadopoulou Evdokia,Fasoulaki Virginia,Giatromanolaki Alexandra

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference31 articles.

1. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. 1;Bolla;N Engl J Med,1997

2. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. 1;Denham;Lancet Oncol,2011

3. Efficacy and safety of enzalutamide vs bicalutamide in younger and older patients with metastatic castration resistant prostate cancer in the TERRAIN trial;Siemens;J Urol,2018

4. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study;Ryan;Lancet Oncol,2015

5. ARN-509: a novel antiandrogen for prostate cancer treatment;Clegg;Cancer Res,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming resistance in prostate cancer with targeted and small molecule-based therapies;Therapy Resistance in Prostate Cancer;2024

2. Relative search popularity of five advanced prostate cancer medications using Google Trends;Prostate Cancer and Prostatic Diseases;2023-09-08

3. Solubility Profile and Intermolecular Force Analysis of Bicalutamide Form I in Mono Solvents at Several Temperatures;Journal of Chemical & Engineering Data;2023-07-07

4. STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide;Molecular Medicine Reports;2023-01-13

5. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins;Biomolecules;2022-11-19